Biocon gets USFDA approval for generic version of anti-cancer drug

Biocon said that it has received received tentative approval of its ANDA for Dasatinib tablets from the US FDA, for various strengths. This product is indicated for use in the treatment of Philadelphia chromosome positive chronic myeloid leukemia in adults. It is also used to treat Philadelphia chromosome positive acute lymphoblastic leukemia in adults with […]